Curcumin inhibited anaerobic glycolysis by inhibiting the expression of LDH and HIF-1α, which strengthened the anti-HCC effect of sorafenib (Man et al., 2020). The gene discussed is HIF1A; the disease is hepatocellular carcinoma.